Search

everythinglearnresearchcommunity

for

Search:↓

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Baby and adult skin cells are different, with baby cells having more active pathways that could help grow new hair follicles.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with alopecia may have a higher chance of getting thyroid cancer.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with androgenetic alopecia have lower zinc and iron levels.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Women with female pattern hair loss have lower Vitamin D3 levels.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.